메뉴 건너뛰기




Volumn 329, Issue 7474, 2004, Pages 1059-1060

Hepatitis B infections

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

EID: 8544257326     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7474.1059     Document Type: Editorial
Times cited : (14)

References (12)
  • 1
    • 1642410856 scopus 로고    scopus 로고
    • Hepatitis B epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    • Lavanchy D. Hepatitis B epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97–107.
    • (2004) J Viral Hepat , vol.11 , pp. 97-107
    • Lavanchy, D.1
  • 2
    • 1642329320 scopus 로고    scopus 로고
    • Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses
    • Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int 2004; 19: 95–103.
    • (2004) Health Promot Int , vol.19 , pp. 95-103
    • Kermode, M.1
  • 3
    • 8544238274 scopus 로고    scopus 로고
    • London Foundation for Liver Research (accessed 28 Oct 2004)
    • Foundation for Liver Research. Hepatitis B: out of the shadows. London, Foundation for Liver Research, 2004. www.ucl.ac.uk/liver-research/hepatitis-report.pdf (accessed 28 Oct 2004).
    • (2004) Hepatitis B: out of the shadows
  • 4
    • 8544247938 scopus 로고    scopus 로고
    • Preventing and treating hepatitis B infection
    • Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ 2004; 329: 1080–6.
    • (2004) BMJ , vol.329 , pp. 1080-1086
    • Aggarwal, R.1    Ranjan, P.2
  • 7
    • 1442359948 scopus 로고    scopus 로고
    • Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy
    • Hahné S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 2004; 29: 211–20.
    • (2004) J Clin Virol , vol.29 , pp. 211-220
    • Hahné, S.1    Ramsay, M.2    Balogun, K.3    Edmunds, W.J.4    Mortimer, P.5
  • 8
    • 0032446372 scopus 로고    scopus 로고
    • Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England
    • Lamden KH, Kennedy N, Beeching NJ, Lowe D, Morrison CL, Mallinson H, et al. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infect 1998; 37: 260–9.
    • (1998) J Infect , vol.37 , pp. 260-269
    • Lamden, K.H.1    Kennedy, N.2    Beeching, N.J.3    Lowe, D.4    Morrison, C.L.5    Mallinson, H.6
  • 10
    • 0037283535 scopus 로고    scopus 로고
    • Hepatitis B vaccine-do we need boosters?
    • Banatvala JE, van Damme P. Hepatitis B vaccine-do we need boosters? J Viral Hepat 2003; 10: 1–6.
    • (2003) J Viral Hepat , vol.10 , pp. 1-6
    • Banatvala, J.E.1    van Damme, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.